Advansource Biomaterials Corporation has a market cap of $0.5 million; its shares were traded at around $0.031 with and P/S ratio of 0.2.
This is the annual revenues and earnings per share of ASNB over the last 10 years. For detailed 10-year financial data and charts, go to 10-Year Financials of ASNB.
CEO Recent Trades:
- CEO Michael F Adams bought 7,061 shares of ASNB stock on 12/03/2012 at the average price of 0.04. Michael F Adams owns at least 366,016 shares after this.
- CEO Michael F Adams bought 7,881 shares of ASNB stock on 11/27/2012 at the average price of 0.03. Michael F Adams owns at least 358,955 shares after this.
- CEO Michael F Adams bought 30,000 shares of ASNB stock on 11/19/2012 at the average price of 0.04. Michael F Adams owns at least 351,074 shares after this.
- CEO Michael F Adams bought 50,000 shares of ASNB stock on 08/18/2012 at the average price of 0.03. Michael F Adams owns at least 321,074 shares after this.
CFO Recent Trades:
- CFO David Crispino Volpe bought 5,000 shares of ASNB stock on 11/30/2012 at the average price of 0.03. David Crispino Volpe owns at least 110,153 shares after this.
- CFO David Crispino Volpe bought 5,000 shares of ASNB stock on 11/29/2012 at the average price of 0.04. David Crispino Volpe owns at least 105,153 shares after this.
- CFO David Crispino Volpe bought 25,000 shares of ASNB stock on 11/19/2012 at the average price of 0.04. David Crispino Volpe owns at least 100,153 shares after this.
- CFO David Crispino Volpe bought 75,000 shares of ASNB stock on 09/18/2012 at the average price of 0.02. David Crispino Volpe owns at least 75,153 shares after this.
For the complete insider trading history of ASNB, click here.







RSS